Literature DB >> 23665282

Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis.

Therese Böhm1, Heidi Berger, Marzieh Nejabat, Teresa Riegler, Florian Kellner, Mario Kuttke, Sandra Sagmeister, Monika Bazanella, Klaus Stolze, Anahita Daryabeigi, Nora Bintner, Michael Murkovic, Karl-Heinz Wagner, Rolf Schulte-Hermann, Nataliya Rohr-Udilova, Wolfgang Huber, Bettina Grasl-Kraupp.   

Abstract

BACKGROUND & AIMS: Obesity and hepatic steatosis are frequently associated with the development of a non-alcoholic steatohepatitis (NASH). The mechanisms driving progression of a non-inflamed steatosis to NASH are largely unknown. Here, we investigated whether ingestion of peroxidized lipids, as being present in Western style diet, triggers the development of hepatic inflammation.
METHODS: Corn oil containing peroxidized fatty acids was administered to rats by gavage for 6 days. In a separate approach, hepatocytes (HC), endothelial (EC) and Kupffer cells (KC) were isolated from untreated livers, cultured, and incubated with peroxidized linoleic acid (LOOH; linoleic acid (LH) being the main fatty acid in corn oil). Samples obtained from in vivo and in vitro studies were mainly investigated by qRT-PCR and biochemical determinations of lipid peroxidation products.
RESULTS: Rat treatment with peroxidized corn oil resulted in increased hepatic lipid peroxidation, upregulation of nitric oxide synthetase-2 (NOS-2), cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNFα), elevation of total nitric oxides, and increase in cd68-, cd163-, TNFα-, and/or COX-2 positive immune cells in the liver. When investigating liver cell types, LOOH elevated the secretion of TNFα, p38MAPK phosphorylation, and mRNA levels of NOS-2, COX-2, and TNFα, mainly in KC. The elevation of gene expression could be abrogated by inhibiting p38MAPK, which indicates that p38MAPK activation is involved in the pro-inflammatory effects of LOOH.
CONCLUSIONS: These data show for the first time that ingestion of peroxidized fatty acids carries a considerable pro-inflammatory stimulus into the body which reaches the liver and may trigger the development of hepatic inflammation.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COX-2; EC; HC; IL-1β; IL6; KC; Kupffer cells; LH; LOOH; Lipid peroxidation; NASH; NO-synthetase 2; NOS-2; NPC; OIL; PO; RNS; ROS; TNFα; WA; Western style diet; cyclooxygenase-2; endothelial cells; hepatocytes; interleukin-1β; interleukin-6; linoleic acid; native corn oil; non-ethanol-induced steatohepatitis; non-parenchymal liver cells; peroxidized corn oil; peroxidized linoleic acid; reactive nitrogen species; reactive oxygen species; tumor necrosis factor α; water

Mesh:

Substances:

Year:  2013        PMID: 23665282     DOI: 10.1016/j.jhep.2013.04.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

Review 2.  Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development.

Authors:  Ilaria Peluso; Husseen Manafikhi; Raffaella Reggi; Maura Palmery
Journal:  Eur J Nutr       Date:  2015-03-16       Impact factor: 5.614

3.  The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro.

Authors:  Otto Kučera; René Endlicher; Tomáš Roušar; Halka Lotková; Tomáš Garnol; Zdeněk Drahota; Zuzana Cervinková
Journal:  Oxid Med Cell Longev       Date:  2014-03-31       Impact factor: 6.543

Review 4.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

Review 5.  The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.

Authors:  Marina Nati; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.349

6.  Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice.

Authors:  Susanne Schuster; Casey D Johnson; Marie Hennebelle; Theresa Holtmann; Ameer Y Taha; Irina A Kirpich; Akiko Eguchi; Christopher E Ramsden; Bettina G Papouchado; Craig J McClain; Ariel E Feldstein
Journal:  J Lipid Res       Date:  2018-07-03       Impact factor: 5.922

7.  Identification and application of anti-inflammatory compounds screening system based on RAW264.7 cells stably expressing NF-κB-dependent SEAP reporter gene.

Authors:  Yue Li; Xiaomeng Wang; Juan Ren; Xi Lan; Jing Li; Jing Yi; Li Liu; Yan Han; Sanqi Zhang; Dongmin Li; Shemin Lu
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-18       Impact factor: 2.483

Review 8.  Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.

Authors:  Priscila Silva Figueiredo; Aline Carla Inada; Gabriela Marcelino; Carla Maiara Lopes Cardozo; Karine de Cássia Freitas; Rita de Cássia Avellaneda Guimarães; Alinne Pereira de Castro; Valter Aragão do Nascimento; Priscila Aiko Hiane
Journal:  Nutrients       Date:  2017-10-22       Impact factor: 5.717

Review 9.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

10.  Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis.

Authors:  Amal Hassanin; Hala Abdel Malek; Dalia Saleh
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.